Scholamed

PGPPC Program over view page for accreditation

Collaborated With

National Health Service

Indian Medical Association

The Indian Pharmaceutical Association (IPA)

Chapter 10 hrs

Credit Point

View Course

This course includes

Language: English

Certificate of Completion

Course Title: “PGPPC - Post-Graduate Program in Pediatric Clinical Care”
Course Duration: Approx. 3 hours of self-paced learning to be completed
Course type- Online- E-learning Material (ELM)

Course Title: “PGPPC - Post-Graduate Program in Pediatric Clinical Care”
Course Duration: Approx. 3 hours of self-paced learning to be completed
Course type: Online- E-learning Material (ELM)

About this course:
The curriculum allows pediatricians to update themselves with current research and also learn from the experiences of fellow colleagues. The program titled “PGPPC - Post-Graduate Program in Pediatric Clinical Care”, comprises three important modules.

MODULE I
The discussion in the first module titled “Navigating Pediatric Obesity: Advanced Therapies Unveiled” revolves around the guidelines and challenges to management of obesity in childhood. It emphasizes the importance of early diagnosis and intervention as children with obesity are at higher risk for several medical conditions such as metabolic syndrome, insulin resistance, high blood pressure, and hyperlipidemia.

MODULE II
The second module “Unlocking ADHD Management Strategies: Beyond the Classroom” guides the pediatrician to early diagnosis of ADHD in children and adolescents. It gives insights concerning pharmacological and behavioral therapies in ADHD.

MODULE III
The third module on “Healing Hands: Integrative Approaches to Pediatric Chronic Abdominal Pain” helps the pediatrician to navigate the integrative/nonpharmacologic approaches to treat common pediatric gastrointestinal complaints and understand pain neuroscience education.

Intended Audience
Pediatricians in India and Sri-Lanka, who offer clinical care and consultation to children.

Learning objectives:
After successful completion of the program, the participant is likely to understand:
1. The challenges and guidelines in managing pediatric obesity
2. The significance of early diagnosis and management of ADHD
3. The implementation of the Rome IV framework and its impacts on pediatric abdominal pain diagnosis and therapy

Dr. Vaman Khadilkar
Senior Pediatric & Adolescent Endocrinologist, Jehangir Hospital, Pune

Prof. Dr. Senthil Senniappan
Consultant Pediatric Endocrinologist & Clinical Director for Endocrinology,Alder Hey Children’s Hospital Liverpool, England, UK

Prof. Dr. Sven Bölte
Director of the Center for Neurodevelopmental Disorders at Karolinska Institutet (KIND). Stockholm, Sweden

Dr. Pritam Chandak
Consultant Child & Adolescent Psychiatrist Synapse Mind & Child Development Centre Nagpur

Dr. Vasant M. Khalatkar
National President, 2025, Indian Academy of Pediatrics (IAP)
National President, Commonwealth Association for Health & Disability (COMHAD), UK

Dr. Neelam Mohan
President-Elect (IAP) 2025,
Senior Director and HOD - Pediatric Gastroenterology, Hepatology & Liver
Transplantation Medanta, Gurugram

Accreditation Statement
This activity is organized by Insignia Communication Ltd.

Physician Accreditation Statement - EACCME
EACCME accreditation is pending.

Physician Credit Designation – EACCME
EACCME accreditation is pending.

Educational Grant
This educational activity is independently produced and is financially supported with an unrestricted educational grant by Zynova Pharmaceutical.

Method of Participation:
Participants should first read the objectives and other introductory CME information and then proceed to the educational activity. If a pre-and post-test is required to receive credit for this activity, participants must complete the post-test and then complete the evaluation.

Course Development details
The following faculty stated they have no financial relationships with ineligible companies:
Dr Shwetal Sanghvi, Clinical Content Reviewer has stated she has no financial relationships with ineligible companies.
Ms Aditi Munghate, Insignia Communications Planner, stated they have no financial relationships with ineligible companies.

To resolve identified/potential conflicts of interest, the educational content was fully reviewed by a Clinical Content Review Committee which has nothing to disclose. The resulting certified activity was found to provide educational content that is current and evidence-based to protect learners from commercial bias and marketing.

Off-label Statement
This educational activity may contain a discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.

Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Insignia Communications. This material is prepared based upon a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject.

View Course

This course includes

Language: English

Certificate of Completion

Explore Courses

See All